Search research articles
Contact Us
Filters
Showing results (91-100 of 104) with videos related to
Page
of 11
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 27, 2022
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4
Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 27, 2021
Reply
Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 8, 2022
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5
Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
The Journal of Arthroplasty
|
February 9, 2019
Increased Staphylococcus aureus Nasal Carriage Rates in Rheumatoid Arthritis Patients on Biologic Therapy
Susan M Goodman, Allina A Nocon, Nicolas A Selemon, et al.
Clinical Rheumatology
|
November 21, 2015
Fellow use of medical jargon correlates inversely with patient and observer perceptions of professionalism: results of a rheumatology OSCE (ROSCE) using challenging patient scenarios
Jessica R Berman, Juliet Aizer, Anne R Bass, et al.
Annals of the Rheumatic Diseases
|
April 12, 2026
Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study
Deanna P Jannat-Khah, Pankti Reid, Laura C Cappelli, et al.
Journal for Immunotherapy of Cancer
|
May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study
Alice Tison, Deanna Jannat-Khah, Laura C Cappelli, et al.
Annals of the Rheumatic Diseases
|
April 5, 2023
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis
Anne R Bass, Noha Abdel-Wahab, Pankti D Reid, et al.
Seminars in Arthritis and Rheumatism
|
November 13, 2022
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group
Nilasha Ghosh, Nina Couette, Wouter H van Binsbergen, et al.
Science Immunology
|
July 28, 2023
Clonally expanded CD38<sup>hi</sup> cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor-associated arthritis
Runci Wang, Anvita Singaraju, Kathryne E Marks, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 104) with videos related to
Sort By:
Page
of 11
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 27, 2022
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4
Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 27, 2021
Reply
Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 8, 2022
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5
Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
The Journal of Arthroplasty
|
February 9, 2019
Increased Staphylococcus aureus Nasal Carriage Rates in Rheumatoid Arthritis Patients on Biologic Therapy
Susan M Goodman, Allina A Nocon, Nicolas A Selemon, et al.
Clinical Rheumatology
|
November 21, 2015
Fellow use of medical jargon correlates inversely with patient and observer perceptions of professionalism: results of a rheumatology OSCE (ROSCE) using challenging patient scenarios
Jessica R Berman, Juliet Aizer, Anne R Bass, et al.
Annals of the Rheumatic Diseases
|
April 12, 2026
Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study
Deanna P Jannat-Khah, Pankti Reid, Laura C Cappelli, et al.
Journal for Immunotherapy of Cancer
|
May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study
Alice Tison, Deanna Jannat-Khah, Laura C Cappelli, et al.
Annals of the Rheumatic Diseases
|
April 5, 2023
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis
Anne R Bass, Noha Abdel-Wahab, Pankti D Reid, et al.
Seminars in Arthritis and Rheumatism
|
November 13, 2022
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group
Nilasha Ghosh, Nina Couette, Wouter H van Binsbergen, et al.
Science Immunology
|
July 28, 2023
Clonally expanded CD38<sup>hi</sup> cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor-associated arthritis
Runci Wang, Anvita Singaraju, Kathryne E Marks, et al.
Page
of 11